These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21449881)

  • 1. Breast cancer: novel therapeutic targets.
    Yip GW
    Recent Pat Anticancer Drug Discov; 2011 May; 6(2):164-5. PubMed ID: 21449881
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug transport-based therapeutic resistance in breast cancer liver metastases.
    Park K
    J Control Release; 2018 Dec; 291():196. PubMed ID: 30446080
    [No Abstract]   [Full Text] [Related]  

  • 3. Locally advanced and inflammatory breast cancer.
    Chia S; Swain SM; Byrd DR; Mankoff DA
    J Clin Oncol; 2008 Feb; 26(5):786-90. PubMed ID: 18258987
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging drugs in metastatic breast cancer.
    Dizdar O; Altundag K
    Expert Opin Emerg Drugs; 2009 Mar; 14(1):85-98. PubMed ID: 19278368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted drug delivery for breast cancer treatment.
    Jin S; Ye K
    Recent Pat Anticancer Drug Discov; 2013 May; 8(2):143-53. PubMed ID: 23394116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic targeting in breast cancer].
    Penault-Llorca F
    Ann Pathol; 2009 Nov; 29 Spec No 1():S71-3. PubMed ID: 19887259
    [No Abstract]   [Full Text] [Related]  

  • 7. Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer.
    Wang B; Rosano JM; Cheheltani R; Achary MP; Kiani MF
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1159-73. PubMed ID: 20738211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic targets in triple negative breast cancer - where are we now?
    Teng YH; Thike AA; Wong NS; Tan PH
    Recent Pat Anticancer Drug Discov; 2011 May; 6(2):196-209. PubMed ID: 21247402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
    Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
    Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging therapeutic targets in breast cancer bone metastasis.
    Rose AA; Siegel PM
    Future Oncol; 2010 Jan; 6(1):55-74. PubMed ID: 20021209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spotlight on trastuzumab as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer.
    Garnock-Jones KP; Keating GM; Scott LJ
    BioDrugs; 2010 Jun; 24(3):207-9. PubMed ID: 20462285
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanoparticle delivery for metastatic breast cancer.
    Grobmyer SR; Zhou G; Gutwein LG; Iwakuma N; Sharma P; Hochwald SN
    Nanomedicine; 2012 Sep; 8 Suppl 1():S21-30. PubMed ID: 22640908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular phenotypes of breast cancer and their clinical application].
    Tang P; Wei B; Hicks DG; Skinner K; Bu H
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):13-7. PubMed ID: 19489219
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone targeted therapy in breast cancer: present and future.
    Huober J; Thürlimann B
    Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S7-10. PubMed ID: 20427030
    [No Abstract]   [Full Text] [Related]  

  • 15. Nanotechnology: An Emerging Therapeutic Option for Breast Cancer.
    Hussain Z; Khan JA; Murtaza S
    Crit Rev Eukaryot Gene Expr; 2018; 28(2):163-175. PubMed ID: 30055543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery approaches for breast cancer.
    Singh SK; Singh S; Lillard JW; Singh R
    Int J Nanomedicine; 2017; 12():6205-6218. PubMed ID: 28883730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hitting multiple targets in HER2-positive breast cancer: proof of principle or therapeutic opportunity?
    Geuna E; Milani A; Redana S; Rossi V; Valabrega G; Aglietta M; Montemurro F
    Expert Opin Pharmacother; 2011 Mar; 12(4):549-65. PubMed ID: 21208143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting mitochondrial function for the treatment of breast cancer.
    Deus CM; Coelho AR; Serafim TL; Oliveira PJ
    Future Med Chem; 2014 Sep; 6(13):1499-513. PubMed ID: 25365234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-based micro-composite drug carriers with dual chemo-agents for targeted breast cancer treatment.
    Abedin F; Anwar MR; Asmatulu R; Yang SY
    J Biomater Appl; 2015 Jul; 30(1):38-49. PubMed ID: 25638169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes as targeted drug delivery systems in the treatment of breast cancer.
    Sharma G; Anabousi S; Ehrhardt C; Ravi Kumar MN
    J Drug Target; 2006 Jun; 14(5):301-10. PubMed ID: 16882550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.